Olaford 5 Tablet contains Olanzapine 5 mg, an atypical antipsychotic agent primarily indicated for the treatment of schizophrenia and bipolar disorder. Olanzapine exerts its therapeutic effects by modulating the activity of various neurotransmitters in the brain, particularly dopamine and serotonin receptors, which helps to restore the chemical balance and alleviate symptoms such as hallucinations, delusions, mood swings, and agitation. This medication is effective in managing both acute psychotic episodes and maintenance therapy to prevent relapse. Olaford 5 Tablet is typically administered orally once daily, with dosage adjustments based on clinical response and tolerability. Common adverse effects may include weight gain, sedation, dry mouth, dizziness, and metabolic changes such as increased blood glucose and lipid levels; therefore, regular monitoring of metabolic parameters is recommended during treatment. Caution is advised in patients with a history of cardiovascular disease, diabetes, or seizures. Olaford 5 Tablet should be used under strict medical supervision, and abrupt discontinuation should be avoided to prevent withdrawal symptoms or relapse. It is contraindicated in individuals with known hypersensitivity to olanzapine or any of its excipients. This medication should be stored at room temperature, away from moisture and direct light.